Jane Street
BHVN

Jane Street’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Jane Street’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-55,500
Closed -$8.39M – 10958
2022
Q3 		$8.39M Sell
55,500
-52,600
-49% -$7.8M ﹤0.01% 1882
2022
Q2 		$15.8M Sell
108,100
-12,700
-11% -$1.62M 0.01% 1318
2022
Q1 		$14.3M Buy
120,800
+56,100
+87% +$7M ﹤0.01% 1586
2021
Q4 		$8.92M Sell
64,700
-86,000
-57% -$10.9M ﹤0.01% 2028
2021
Q3 		$20.9M Buy
150,700
+126,000
+510% +$15.7M 0.01% 1111
2021
Q2 		$2.4M Buy
24,700
+13,600
+123% +$1.1M ﹤0.01% 3983
2021
Q1 		$759K Sell
11,100
-25,200
-69% -$2.04M ﹤0.01% 6001
2020
Q4 		$3.11M Buy
36,300
+23,800
+190% +$2.02M ﹤0.01% 2770
2020
Q3 		$813K Sell
12,500
-112,600
-90% -$7.38M ﹤0.01% 4430
2020
Q2 		$9.15M Buy
125,100
+62,600
+100% +$3.33M 0.01% 1256
2020
Q1 		$2.13M Buy
62,500
+53,800
+618% +$2.46M ﹤0.01% 1961
2019
Q4 		$474K Sell
8,700
-20,500
-70% -$1.02M ﹤0.01% 3749
2019
Q3 		$1.22M Buy
+29,200
New +$1.23M ﹤0.01% 2369

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Jane Street's BHVN Position: Q4 2022 in Review

Jane Street sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 30,716 shares — an estimated $4.64M sold.

Jane Street first reported a position in BHVN in Q1 2018 and held it in 17 quarters. The position peaked at $8.4M in Q2 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Jane Street reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 30,716 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $4.64M.
  • Jane Street first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 17 quarters.
  • Jane Street's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $8.4M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.